Myriad Genetics, Inc. (MYGN) Profit Margins
Over the twelve months to 2026-06-30, Myriad Genetics, Inc. (MYGN) had gross margin 68.8%, operating margin -12.2%, net margin -14.0%, free cash flow margin -0.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
MYGNMyriad Genetics, Inc.Follow MYGN — free
—
Price chart with a free account
- Market cap
- 556.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
| Line | FY2011 Jun 11 | FY2012 Jun 12 | FY2013 Jun 13 | FY2014 Jun 14 | FY2015 Jun 15 | FY2016 Jun 16 | FY2017 Jun 17 | FY2018 Jun 18 | FY2019 Jun 19 | FY2020 Jun 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 88.6% | 89.6% | 89.5% | 87.7% | 81.6% | 82.4% | 81.2% | — | — | — | — | — | 68.6% | 69.9% | 69.9% | 68.8% | |
| Operating margin | 39.2% | 36.4% | 37.2% | 35.3% | 18.5% | 20.4% | 5.7% | 16.4% | 0.9% | -36.3% | -27.6% | -20.7% | -34.2% | -14.7% | -47.0% | -12.2% | |
| Net margin | 25.0% | 22.6% | 24.0% | 22.6% | 11.0% | 15.5% | 2.3% | 17.9% | 0.5% | -31.2% | -3.9% | -16.5% | -35.0% | -15.2% | -44.4% | -14.0% | |
| FCF margin | 32.5% | 28.6% | 26.5% | 22.6% | 16.1% | 21.4% | 13.0% | 14.5% | 8.8% | 7.9% | 0.1% | -22.3% | -23.1% | -3.3% | -1.7% | -0.9% |
USD billions · SEC XBRL
Myriad Genetics, Inc. — questions
- What is Myriad Genetics, Inc.'s gross margin?
- 68.8% over the twelve months to 2026-06-30.
- What is Myriad Genetics, Inc.'s operating margin?
- -12.2% over the twelve months to 2026-06-30.
- What is Myriad Genetics, Inc.'s net profit margin?
- -14.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Myriad Genetics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.